|
|
|
LifeScienceHistory.com - Check us out on Instagram
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Selecta Biosciences
| | | Phone: | (617) 923-1400 | Fax: | (617) 924-3454 | Year Established: | 2007 | Employees: | 25 | Main Contact: | Peter Keller, M.Sci., VP, Business Development & Alliance Management | | Other Contacts: | Earl Sands, M.D., CMO David Siewers, VP, Finance David Abraham, J.D., General Counsel & Corporate Secretary Takashi Kei Kishimoto, Ph.D., CSO Lloyd Johnston, Ph.D., COO & Senior VP, R&D Werner Cautreels, Ph.D., President & CEO
| | Company Description | Selecta Biosciences is a clinical-stage biopharmaceutical company developing targeted immunotherapies and vaccines that are designed to modulate immune responses to treat and prevent disease. Selecta’s proprietary Synthetic Vaccine Particle (SVP™) platform has the potential to create a new paradigm in immunology and may enable a novel approach for selectively targeting the immune system to effectively and safely treat and prevent rare and serious diseases. | |
|
|
|
|
|